Next Article in Journal
Concern about the Effects of the Pandemic Caused by COVID-19 in the Retail Sector in Spain. Differences between Men and Women
Previous Article in Journal
The Electrochemical Behavior of Methotrexate upon Binding to the DNA of Different Cell Lines
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Health State Valuation and Its Socio-Economic Factors: Online Samples from the U.S. and Canada †

Department of Economics, Concordia University, 1455 de Maisonneuve Blvd. West, Montreal, QC H3G 1M8, Canada
Presented at the 3rd International Electronic Conference on Environmental Research and Public Health—Public Health Issues in the Context of the COVID-19 Pandemic, 11–25 January 2021; Available online: https://ecerph-3.sciforum.net/.
Med. Sci. Forum 2021, 4(1), 4; https://doi.org/10.3390/ECERPH-3-09000
Published: 11 January 2021

Abstract

:
This paper seeks to explore how people value the state of health and what socio-economic factors they might consider. I conducted an online experiment and a survey to elicit individuals’ decisions under hypothetical health states, which vary at three levels: mild, moderate, and severe. The socio-economic factors mainly include payment, personal financial situation, hospital service, support from their family, etc. The subjects were from two separate online pools of the United States and Canada, which have similar socio-economic backgrounds and different health care systems. This paper presents that subjects are sensitive to different levels of health states. In those who choose the risky medical treatment under the same health states, the Canadian participants are willing to accept a lower success probability. Among the socio-economic factors that are significant to this health-related decision, some factors are only significant in one country’s participants. For the American sample, it is “access to health insurance”, while for the Canadian sample, it is “disturbances in everyday family life”.

1. Introduction

The fundamental purpose of a health service is to enhance the quality of life by maintaining or improving one’s health status. Medical treatments can achieve great improvements in people’s health but may also cause negative consequences. When patients choose between remaining in ill health and taking a risky treatment, they may consider different key factors. Patients may face the risk of failure of treatment and/or the financial cost of receiving the treatment. Even under publicly funded health care for which patients will not need to make the payment out of their pockets, they still have to consider other factors, such as income deduction, disturbance of daily life, and support from their family. This paper aims to explore the socio-economic elements that people may consider when valuing the state of ill health.

2. Methods

2.1. Health State Valuation

The term “health state” used in this project is originally rooted in the concept of the quality-adjusted life-year (QALY) in Health Economics, which defines the desirability of a health state based on how an individual would value being in that health state themself. Individual decisions are governed by individual ex-ante preferences [1].
The dimensions of health state used in this paper are based on the SF-6D, which was a six-dimensional health state classification (Brazier, Usherwood, Harper, & Thomas, 1998) [2]. The six dimensions that are in order are physical functioning, role limitations, social functioning, pain, mental health, and vitality. Each of the six digits of the health state indicates the level on each dimension of the SF-6D. Among the reported 24 health states, I filter three health states which are considered as mild, moderate, and severe (Health State A 111212, Health State B 422413, and Health State C 625655). All three health states were presented to the participants one after the other, each in a pre-determined order designed for randomness. After being notified of one health state, the subjects valued this health state in a modified Health States Standard Gamble (SG). They decided whether or not they would take this risky treatment to improve their health and what probability of success they will accept in the outcome of the treatment table. In this valuation, the success probability P which is accepted by the subject is called the standard gamble value (SG value hereafter).

2.2. Socio-Economic Questionnaire

The second part of the experiment is a questionnaire, which examines participants’ healthcare background, payment methods, and other socio-economic factors.
Based on the fact that participants are from the United States and Canada, this paper categorizes the medical payment into three groups: the public, the private, and the uninsured [3]. In the survey, the private group is specified as employer-purchase and personal-purchase.

2.3. Research Questions

There are three steps in the whole experiment. The “Preface” questions are purposely placed before the SG during step 1, serving as a “refreshment” for the participants” memory of their medical experiences. In step 2, the participants were given a standard gamble for each of the three health states. The “Follow-up” questionnaire is done right after step 2 and explores the socio-economic factors.
This paper aims to answer the following questions:
1. Will participants in both countries distinguish between the three health states and make corresponding decisions in each state?
2. Will decisions on the health state standard gamble vary between the two countries? Is this difference consistent across all health states?
3. Are there any common components of the payment system and socio-economic factors involved in a healthy state’s valuation? Are these components consistent across the three health states in each nation?
4. How will these common components affect health-related decisions, and to what extent will the two countries vary in their respective features?

2.4. Experimental Procedure

I designed the experiment for the two countries and coded the United States version with oTree [4]. The samples from the two countries were collected from two separate platforms. The U.S. version was conducted on the online labor force platform Amazon Mechanical Turk (MTurk). For the Canadian version, the researcher cooperated with the third party AskCanadians. AskCanadians’ posting period is 24–30 March 2020 and MTurk’s posting period is 27 March–2 April 2020.

3. Results

3.1. Summary of the Demographic Information

There are 200 participants from each country. The Canadian sample covers all 10 provinces, and the four largest proportions of participants are from Ontario, Quebec, British Columbia, and Alberta. The American participants come from 38 states. The Kolmogorov–Smirnov test shows that there is no significant difference in the income distribution between the two countries (one-tailed, p = 0.299). The highest percentage in the American sample is 23%, for the category of $75,000 to $99,999; while the highest proportion in the Canadian sample is 24%, for the category of $100,000 or greater. The Kolmogorov–Smirnov test shows that the Canadian participants are significantly younger than the American participants (one-tailed, p = 0.000). The highest percentage in the Canadian sample is 48.5%, which is the age group of 25–34, while the highest percentage in the American sample is 20%, which is the age group of 45–54. One Canadian participant selected “Other” in gender; besides that, 52% was female in the Canadian sample and 43.5% was female in the American sample.

3.2. Findings

3.2.1. Finding 1: (Comparison across Health States)

When the health state worsened, the participants were willing to accept a risky medical treatment with a lower probability of success. This finding holds for both samples.
The paired t-tests (see Table 1) generally support the results found in the statistical summary. The SG value decreases as the health state deteriorates. All comparisons between the three health states are significant for the Canadian participants. For American participants, however, this difference between SG1 and SG2 does not appear to be significant. As a robust check, the tests are also done with the data excluding the SG = 0 and violate monotonicity. Compared to the original data, the excluding data show SG1 > SG2 is significant in the USA.

3.2.2. Finding 2: (Comparison across Samples)

More Canadian participants chose “No-Treatment” than American participants in all three health states. Conditional on choosing “Treatment”, the American participants had significantly higher SG values than Canadian participants, regardless of the health state they were given.
The box plot (see Figure 1) shows the SG value distribution of the two-group participants. Comparing the box by countries, the boxes of Canadian samples are lower than those of American samples in moderate and severe health states. This conclusion is supported by the results shown in Table 2. The t-test shows that for all health states, the SG value in American samples is higher than Canadian’s, all of which is statistically significant at the 95% confidence level.

3.3.3. Finding 3: (Comparison in PCA)

Between the two countries’ samples, the principal component analysis (PCA) components in the “Source of medical payment” are the same, but the PCA components in the “Personal factor” category are not identical.
This paper applies the principal component analysis (PCA) to the original factors reported in the questionnaire (see Table 3). Unlike the original separate factors, the scores of the components are not correlated. Each component is renamed as a meaningful variable.

3.3.4. Finding 4: (Comparison across Samples)

In the health state valuation, many factors are significant in both countries’ participants, such as “employer-purchased insurance plans”, “waiting time for the treatment”, and “personal financial situation”. However, the two countries’ participants also show different considered factors. For the American sample, it is “access to health insurance”, while for the Canadian sample, it is “disturbances in everyday family life”.
By regressing the SG value with PCA factor scores, this paper shows which factors may be associated with health state valuation (see Table 4). After tracing the PCA factors back to the original factors in the survey, I summarize the factors in Table 5.

4. Discussion

For future research, larger sample sizes may be considered for comparative studies in these two countries. This paper has a sample size of 200 participants for each country. Most of the results could have wider implications with larger sample sizes. In the survey, subjects make decisions based on a hypothetical health state that is designed to be comparable and measurable between different people. However, a person’s actual health status could be an interesting variable that could be added to the experiment.

5. Conclusions

From an individual’s view, health-related decisions may be associated with multiple socio-economic factors. This paper explores these decisions and factors through a survey experiment based on two online samples.

Funding

This research was funded by SSHRC Insight Development Grant. File Number: 430-2018-00929.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of Concordia University (Certification Number: 30012708 and Valid From: 6 March 2020 To: 5 March 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The author would like to thank all those who participated in this study, particularly Huan Xie from Concordia University and Thomas G. Poder from the University of Montreal.

Conflicts of Interest

The author identifies and declares no personal circumstances or interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results.

References

  1. Weinstein, M.C.; Torrance, G.; McGuire, A. QALYs: The Basics. Value Health 2009, 12, S5–S9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Brazier, J.; Usherwood, T.; Harper, R.; Thomas, K. Deriving a preference based single index measure from the SF-36. J. Clin. Epidemiol. 1998, 51, 1115–1128. [Google Scholar] [CrossRef]
  3. Miller, E.; Banthin, J.S.; Moeller, J.F. Covering the Uninsured: Estimates of the Impact on Total Health Expenditures for 2002; Working Paper No. 04007; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2004. Available online: http://www.ahrq.gov (accessed on 4 November 2019).
  4. Chen, D.L.; Schonger, M.; Wickens, C. oTree-An open-source platform for laboratory, online and field experiments. J. Behav. Exp. Financ. 2016, 9, 88–97. [Google Scholar] [CrossRef]
Figure 1. Box plot for health state standard gamble (SG) value (conditional on choosing Option B). US: United States sample. CA: Canadian sample.
Figure 1. Box plot for health state standard gamble (SG) value (conditional on choosing Option B). US: United States sample. CA: Canadian sample.
Msf 04 00004 g001
Table 1. Paired t-test on the SG values between the three states.
Table 1. Paired t-test on the SG values between the three states.
The Paired Two-Tailed t-Test of the American Sample
Hypothesis (H0)SG1 = SG2SG2 = SG3SG1 = SG3
Pr (|T| >| t|)0.12370.0012 ***0.0007 ***
[95% Conf. Interval of diff][−0.86, 7.07][3.00, 12.00][4.32, 15.71]
Paired obs.161173163
Result (H1)SG1 > SG2SG2 > SG3SG1 > SG3
The Paired Two-Tailed t-Test of the Canadian Sample
Hypothesis (H0)SG1 = SG2SG2 = SG3SG1 = SG3
Pr (|T| >| t|)0.0010 ***0.0000 ***0.0000 ***
[95% Conf. Interval of diff][2.99, 11.52][11.77, 20.84][14.85, 27.13]
Paired obs.151168151
Result (H1)SG1 > SG2SG2 > SG3SG1 > SG3
*** p < 0.01.
Table 2. Paired two-tailed t-test on the SG value between the two samples.
Table 2. Paired two-tailed t-test on the SG value between the two samples.
Health State 1Health State 2Health State 3
Hypothesis (H0)USA = CAUSA = CAUSA = CA
Pr (|T| > |t|)0.0371 **0.0013 ***0.00000 ***
[95% Conf. Interval of diff][−0.70, 15.03][4.06, 19.09][10.50, 24.58]
Combined obs.326355371
Result (H1)USA > CAUSA > CAUSA > CA
*** p < 0.01, ** p < 0.05.
Table 3. PCA components.
Table 3. PCA components.
American Sample Category ASource of Medical Payment
Payment Factor—IndividualSelf-purchased insurance plans
Out-of-pocket payments
Payment Factor—GovernmentGovernment-provided health insurance
Payment Factor—EmploymentEmployer (current, former)-purchased insurance plans
Cumulative0.8477
Kaiser-Meyer-Olkin0.5446
American Sample Category BPersonal Factor
Personal Factor-FinancialAccess to health insurance
Personal financial situation
Personal Factor—Service and SupportWaiting time for the treatment
Service of hospitals
Support from family or friends
Personal Factor—Daily LifeDisturbances in everyday family life
Cumulative0.7415
Kaiser-Meyer-Olkin0.7227
Canadian Sample Category ASource of Medical Payment
Payment Factor—IndividualSelf-purchased insurance plans
Out-of-pocket payments
Payment Factor—GovernmentGovernment-provided health insurance
Payment Factor—EmploymentEmployer (current, former)-purchased insurance plans
Cumulative0.8266
Kaiser-Meyer-Olkin0.5231
Canadian Sample Category BPersonal Factor
Personal Factor—Service and FinancialWaiting time for the treatment
Service of hospitals
Personal financial situation
Personal Factor—familyDisturbances in everyday family life
Support from family or friends
Personal Factor—insuranceAccess to health insurance
Cumulative0.8802
Kaiser-Meyer-Olkin0.7781
Table 4. Tobit regression of SG value and factors in the two samples.
Table 4. Tobit regression of SG value and factors in the two samples.
USA SG Value CA SG Value
Health State−0.195Health State−0.340 ***
(−0.165) (−0.0825)
Gender−8.563 ***Gender−9.525 ***
(−1.152) (−0.756)
Age−1.241 ***Age−2.205 ***
(−0.344) (−0.196)
Income−0.432Income−1.685 ***
(−0.287) (−0.163)
Lack−7.104 ***Lack−3.486 ***
(−0.942) (−0.46)
Payment Factor—Individual0.273Payment Factor—Individual−1.598 ***
(−0.629) (−0.225)
Payment Factor—Government0.637Payment Factor—Government1.952 ***
(−0.501) (−0.222)
Payment Factor—Employment1.047 *Payment Factor—Employment0.696 ***
(−0.634) (−0.269)
Personal Factor—Financial−1.246 ***Personal Factor—Service and Financial−1.917 ***
(−0.453) (−0.142)
Personal Factor—Service and Support0.915 *Personal Factor—Family1.090 ***
(−0.543) (−0.332)
Personal Factor—Daily Life−0.0171Personal Factor—Insurance0.359
(−0.529) (−0.435)
Constant55.27 ***Constant53.86 ***
(−1.738) (−0.834)
Log likelihood−295.739Log likelihood−402.221
Prob > chi20.000Prob > chi20.000
Observations537Observations503
Number of individuals197Number of individuals187
Notes: (1) Participants that prefer not to answer in medical payment methods: 3 in CA; 1 in USA; (2) Participants that chose “Non-Treatment” in all three health states: 10 in CA and 2 in USA (3) Standard errors in parentheses, *** p < 0.01, * p < 0.1.
Table 5. Summary of the significant factors from the Tobit regression.
Table 5. Summary of the significant factors from the Tobit regression.
AmericaCanada
Source of medical payments
  • employer-purchased insurance plans
  • employer-purchased insurance plans
  • self-purchased insurance plans
  • out-of-pocket payments
  • government-provided health insurance
Personally considered factors
  • waiting time for the treatment
  • service of hospitals
  • personal financial situation
  • support from family or friends
  • access to health insurance
  • waiting time for the treatment
  • service of hospitals
  • personal financial situation
  • support from family or friends
  • disturbances in everyday family life
Exogenous variables
  • gender
  • age
  • lack
  • gender
  • age
  • lack
  • health state
  • income
Notes: The factors in bold are significant in both the American and Canadian samples.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wang, L. Health State Valuation and Its Socio-Economic Factors: Online Samples from the U.S. and Canada. Med. Sci. Forum 2021, 4, 4. https://doi.org/10.3390/ECERPH-3-09000

AMA Style

Wang L. Health State Valuation and Its Socio-Economic Factors: Online Samples from the U.S. and Canada. Medical Sciences Forum. 2021; 4(1):4. https://doi.org/10.3390/ECERPH-3-09000

Chicago/Turabian Style

Wang, Liang. 2021. "Health State Valuation and Its Socio-Economic Factors: Online Samples from the U.S. and Canada" Medical Sciences Forum 4, no. 1: 4. https://doi.org/10.3390/ECERPH-3-09000

Article Metrics

Back to TopTop